
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
ZELA | Copenhagen | DKK | Real-time | |
0NZU | London | DKK | Real-time |
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S was incorporated in 1997 and is based in Søborg, Denmark.
Name | Age | Since | Title |
---|---|---|---|
Richard E. Pratley | - | 2011 | Member of Advisory Board |
Paul Dorian | - | 2011 | Member of Advisory Board |
Bernadette Mary Connaughton | 66 | 2019 | Independent Director |
Ake Lernmark | 79 | 2011 | Member of Advisory Board |
Bernard Charbonnel | - | 2011 | Member of Advisory Board |
Jeffrey Berkowitz | 58 | 2019 | Independent Director |
Gert Van Assche | - | 2011 | Member of Advisory Board |
Alf Gunnar Martin Nicklasson | 69 | 2014 | Independent Chairman of the Board |
Leonard Kruimer | 66 | 2019 | Independent Director |
Kirsten Aarup Drejer | 68 | 2018 | Independent Vice Chairman |
Enrique Alfredo Conterno Martinelli | 59 | 2023 | Member of Advisory Board & Independent Director |
Anneline Nansen | 56 | 2021 | Employee Representative Director |
Lars Pedersen | - | 2024 | Alternate Director |
Elaine Sullivan | 64 | 2023 | Independent Director & Member of Advisory Board |
Nikolaj Frederik Barfoed Beck | 58 | 2020 | Employee Representative Director |
Tanja Erichsen | - | 2024 | Alternate Director |
Cecilie Kold | - | - | Alternate Director |
Katja Hansen | - | 2024 | Alternate Director |
Adam Krisko Nygaard | 41 | 2024 | Employee Representative Director |
Ludovic Tranholm Otterbein | 52 | 2024 | Employee Representative Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review